Deborah Dunsire

Chief Executive Officer, MILLENNIUM PHARMACEUTICALS INC.

Companies

McKesson CorporationBoard member Jun 4, 2024 to now¹
Ultragenyx Pharmaceutical Inc.Board member Apr 10, 2017 to now²
Syros Pharmaceuticals, Inc.Board member Sep 10, 2021 to Jun 7, 2024³
Alexion PharmaceuticalsBoard member Feb 1, 2018 to Jul 23, 2021⁴
Allergan plcBoard member Dec 7, 2006 to Mar 19, 2015⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Ultragenyx Pharmaceutical Inc. RARE38,566 shares⁶$585.0K at $15.17May 14, 2026
Syros Pharmaceuticals, Inc.12,000 shares⁷Jun 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 14, 2026Granted 7,751 shares of Ultragenyx Pharmaceutical Inc.⁶
May 15, 2025Granted 5,740 shares of Ultragenyx Pharmaceutical Inc.⁸
Jun 18, 2024Granted 5,345 shares of Ultragenyx Pharmaceutical Inc.⁹
Jun 1, 2024Exercised options 4,000 shares of Syros Pharmaceuticals, Inc.⁷
Jun 7, 2023Granted 3,860 shares of Ultragenyx Pharmaceutical Inc.¹⁰
Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.¹¹
Jun 24, 2022Granted 3,300 shares of Ultragenyx Pharmaceutical Inc.¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMcKesson Corporation, Board member
2
SEC EDGARUltragenyx Pharmaceutical Inc., Board member
3
SEC EDGARSyros Pharmaceuticals, Inc., Board member
4
SEC EDGARAlexion Pharmaceuticals, Board member
5
SEC EDGARAllergan plc, Board member
6
SEC EDGARUltragenyx Pharmaceutical Inc. shares after the filing of May 14, 2026
7
SEC EDGARSyros Pharmaceuticals, Inc. shares after the filing of Jun 1, 2024
8
SEC EDGARForm 4 filed May 19, 2025
9
SEC EDGARForm 4 filed Jun 20, 2024
10
SEC EDGARForm 4 filed Jun 9, 2023
11
SEC EDGARForm 4 filed Sep 19, 2022
12
SEC EDGARForm 4 filed Jun 28, 2022